Activity of Ceftibuten, Cefaclor, Azithromycin, Clarithromycin, Erythromycin and Telithromycin against Streptococcus pyogenes Clinical Isolates with Different Genotypes and Phenotypes

Publisher： Karger

E-ISSN： 1421-9794|51|5|268-271

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.5, 2005-07, pp. : 268-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Activity of Moxifloxacin Compared to Other Fluoroquinolones against Different Erythromycin-Resistant Phenotypes of Group A β-hemolytic Streptococcus

By  

Chemotherapy, Vol. 46, Iss. 1, 1999-12 ,pp. : 23-27

Karger

Access to resources Recommend Favorite

In vitro Activity of Azithromycin in Combination with Amikacin, Ceftazidime, Ciprofloxacin or Imipenem against Clinical Isolates of Acinetobacter baumannii

By  

Chemotherapy, Vol. 49, Iss. 1-2, 2003-05 ,pp. : 24-26

Karger

Access to resources Recommend Favorite

Anti-Bacterial Activity of Phenolic Compounds against Streptococcus pyogenes

By Macé Sabrina   Hansen Lisbeth Truelstrup   Rupasinghe H.P. Vasantha  

Medicines, Vol. 4, Iss. 2, 2017-05 ,pp. : 25-25

MDPI

Access to resources Recommend Favorite

The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000

By  

Chemotherapy, Vol. 48, Iss. 5, 2002-12 ,pp. : 232-237

Karger

Access to resources Recommend Favorite

Activity of Moxifloxacin and Twelve Other Antimicrobial Agents against 216 Clinical Isolates of Streptococcus pneumoniae

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-02 ,pp. : 90-96

Karger

Access to resources Recommend Favorite